{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:04:33Z","timestamp":1790183073898,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cgfr.co.uk","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.cytogfr.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T15:42:15Z","timestamp":1490283735000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Fernanda Costa Brand\u00e3o","family":"Berti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Lombardi","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Cesar Martelossi","family":"Cebinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleber Paiva","family":"Trugilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Braj\u00e3o de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2017.03.002_bib0005","first-page":"550","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0010","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.ogx.0000221010.82943.8c","article-title":"Human papillomavirus: the burden of infection","volume":"61","author":"Wiley","year":"2006","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0015","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.virol.2013.05.006","article-title":"The E5 proteins","volume":"445","author":"DiMaio","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0020","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0025","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","article-title":"Human papillomavirus genome variants","volume":"445","author":"Burk","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0030","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0035","doi-asserted-by":"publisher","first-page":"7014","DOI":"10.1128\/JVI.79.11.7014-7023.2005","article-title":"Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0040","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000355959","article-title":"The biology of human papillomaviruses","volume":"45","author":"Nguyen","year":"2014","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0045","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0050","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1128\/JVI.00483-12","article-title":"Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR","volume":"86","author":"Cornet","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0055","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.7314\/APJCP.2015.16.3.1151","article-title":"Mutation detection of E6 and LCR genes from HPV 16 associated with carcinogenesis","volume":"16","author":"Mosmann","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0060","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/emph\/eov003","article-title":"Papillomaviruses: viral evolution, cancer and evolutionary medicine","volume":"2015","author":"Bravo","year":"2015","journal-title":"Evol. Med. Public Health"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0065","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.virol.2013.07.008","article-title":"The E4 protein; structure, function and patterns of expression","volume":"445","author":"Doorbar","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0070","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coviro.2015.09.001","article-title":"Human papillomaviruses: shared and distinct pathways for pathogenesis","volume":"14","author":"Galloway","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0075","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-virology-100114-055021","article-title":"Novel functions of the human papillomavirus E6 oncoproteins","volume":"2","author":"Wallace","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0080","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.radonc.2014.08.026","article-title":"Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage","volume":"113","author":"Park","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0085","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"De Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0090","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0095","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"56370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0100","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues \u2013 ProQuest","volume":"7","author":"Woodman","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0110","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.biopha.2014.12.041","article-title":"Overview of high-risk HPV\u2019s 16 and 18 infected cervical cancer: pathogenesis to prevention","volume":"70","author":"Ramakrishnan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0115","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1158\/1055-9965.EPI-10-1108","article-title":"Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women","volume":"20","author":"Winer","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0120","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ogc.2013.03.008","article-title":"LSIL: definition and management","volume":"40","author":"Zsemlye","year":"2013","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002761","article-title":"Large scale genotype comparison of human papillomavirus E2-Host interaction networks provides new insights for E2 molecular functions","volume":"8","author":"Muller","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0135","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00432-008-0413-3","article-title":"The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma","volume":"134","author":"Li","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0140","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/v5112624","article-title":"Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response","volume":"5","author":"Amador-Molina","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0145","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10156-012-0485-5","article-title":"Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer","volume":"18","author":"Sasagawa","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0150","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/eji.200636915","article-title":"Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+and CD8+T cells","volume":"37","author":"Black","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0017848","article-title":"Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes","volume":"6","author":"Karim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0160","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ni.1779","article-title":"RIG-I-dependent sensing of poly (dA: dT) through the induction of an RNA polymerase III \u2212transcribed RNA intermediate","volume":"10","author":"Ablasser","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0165","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/976024","article-title":"Pattern recognition via the toll-like receptor system in the human female genital tract","volume":"2010","author":"Nasu","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0170","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00403-013-1375-0","article-title":"HPV16 activates the AIM2 inflammasome in keratinocytes","volume":"305","author":"Reinholz","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0175","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0180","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS \u2013 STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0185","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.molimm.2011.11.004","article-title":"Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization","volume":"49","author":"Veeranki","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0190","first-page":"997","article-title":"IFI16 is an innate immune sensor for intracellular DNA","volume":"11","author":"Unterholzner","year":"2010","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0195","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.chom.2011.04.008","article-title":"IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to kaposi sarcoma-associated herpesvirus infection","volume":"9","author":"Kerur","year":"2011","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0200","first-page":"5","article-title":"The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response","volume":"38","author":"Dell\u2019Oste","year":"2015","journal-title":"New Microbiol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1002498","article-title":"The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication","volume":"8","author":"Gariano","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0210","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.1128\/JVI.00013-15","article-title":"The nuclear DNA sensor IFI16 acts as a restriction factor for human papillomavirus replication through epigenetic modifications","volume":"89","author":"Lo Cigno","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0215","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1476-4598-9-82","article-title":"Regulation of MCP-1 chemokine transcription by p53","volume":"9","author":"Hacke","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0220","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/JVI.79.1.116-123.2005","article-title":"Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms","volume":"79","author":"Routes","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0225","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.smim.2005.05.009","article-title":"Cutaneous dendritic cells","volume":"17","author":"Valladeau","year":"2005","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0230","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1128\/CMR.05028-11","article-title":"Epithelial cell responses to infection with human papillomavirus","volume":"25","author":"Stanley","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0235","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1002\/eji.201141693","article-title":"Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion","volume":"41","author":"Renoux","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0240","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.coi.2010.04.003","article-title":"Synthetic iNKT cell-agonists as vaccine adjuvants-finding the balance","volume":"22","author":"Cerundolo","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0245","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13000-015-0254-8","article-title":"Accumulation of invariant NKT cells with increased IFN-\u03b3 production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia","volume":"10","author":"Hu","year":"2015","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0250","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00441-010-1023-3","article-title":"Invariant natural killer T cells: bridging innate and adaptive immunity","volume":"343","author":"Van Kaer","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0255","first-page":"266","article-title":"HPV modulation of host immune responses","volume":"65","author":"Feller","year":"2010","journal-title":"SADJ"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0260","doi-asserted-by":"publisher","first-page":"753","DOI":"10.5306\/wjco.v5.i4.753","article-title":"Role of IL-10 and TGF-\u03b21 in local immunosuppression in HPV-associated cervical neoplasia","volume":"5","author":"Torres-Poveda","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0265","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003384","article-title":"Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte\u2019s innate immune response","volume":"9","author":"Karim","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0270","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091473","article-title":"E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-k transcription in keratinocytes","volume":"9","author":"Sunthamala","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0275","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1126\/science.aab3291","article-title":"DNA tumor virus oncogenes antagonize the cGAS-STING DNA sensing pathway","volume":"350","author":"Lau","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0280","doi-asserted-by":"publisher","first-page":"11372","DOI":"10.1128\/JVI.05279-11","article-title":"High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression","volume":"85","author":"Reiser","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0285","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0290","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2015.07.009","article-title":"The paradoxical role of IL-10 in immunity and cancer","volume":"367","author":"Mannino","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0295","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukine-10 and related cytokines and receptors","volume":"22","author":"Pestka","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0300","article-title":"The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0305","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/IGC.0b013e318274b1a2","article-title":"Interleukin 10 polymorphisms and cervical cancer risk: a meta-analysis","volume":"23","author":"Ni","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0310","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3892\/ol.2015.2884","article-title":"Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)","volume":"9","author":"Fernandes","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0315","doi-asserted-by":"publisher","first-page":"11689","DOI":"10.1074\/jbc.M709657200","article-title":"Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin","volume":"283","author":"Stoecklin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0320","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4049\/jimmunol.165.1.292","article-title":"Posttranscriptional regulation of IL-10 gene expression through sequences in the 3\u2019-untranslated region","volume":"165","author":"Powell","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0325","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/mi.2008.33","article-title":"Evolving immunosuppressive microenvironment during human cervical carcinogenesis","volume":"1","author":"Kobayashi","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0330","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0335","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nm0804-801","article-title":"Regulatory T cells and mechanisms of immune system control","volume":"10","author":"O\u2019Garra","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0340","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10 secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0345","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1189\/jlb.1206763","article-title":"Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation","volume":"82","author":"Hu","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0350","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4049\/jimmunol.172.1.567","article-title":"Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages","volume":"172","author":"Williams","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0355","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.4049\/jimmunol.168.12.6404","article-title":"Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation","volume":"168","author":"Berlato","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0360","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.coph.2006.01.010","article-title":"Understanding and exploiting the endogenous interleukin-10\/STAT3-mediated anti-inflammatory response","volume":"6","author":"Murray","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0365","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/107999099313695","article-title":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes","volume":"19","author":"Donnelly","year":"1999","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0370","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4049\/jimmunol.155.3.1079","article-title":"IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes","volume":"155","author":"Finbloom","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0375","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0014-5793(96)00990-8","article-title":"IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes","volume":"394","author":"Wehinger","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0380","first-page":"2","article-title":"Twenty-five years of studies and trials for the therapeutic application of IL-10 immunomodulating properties. From high doses administration to low dose medicine new paradigm","volume":"1","author":"Fioranelli","year":"2014","journal-title":"J. Integr. Cardiol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0385","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2172-11-27","article-title":"Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth","volume":"11","author":"Bolpetti","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0390","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0395","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.0904484","article-title":"New insights into the molecular mechanism of interleukin-10-mediated immunosuppression","volume":"77","author":"Grutz","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0400","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/CCO.0000000000000006","article-title":"Current status of interleukin-10 and regulatory T-cells in cancer","volume":"25","author":"Dennis","year":"2013","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0405","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.autrev.2008.03.001","article-title":"Mechanisms of T regulatory cell function","volume":"7","author":"Askenasy","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0410","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-662-44006-3_7","article-title":"Role of cytokines in tumor immunity and immune tolerance to cancer","author":"Gopal","year":"2015","journal-title":"Cancer Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0415","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O\u2019Garra","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0420","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/bies.201300004","article-title":"Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-g mediated CD8+ T cell cytotoxicity","volume":"35","author":"Mumm","year":"2013","journal-title":"Bioessays"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0425","first-page":"1","article-title":"Interleukin 10 (IL-10) regulatory cytokine and its clinical consequences","author":"Bijjiga","year":"2011","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0430","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0435","doi-asserted-by":"publisher","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","article-title":"Updating the natural history of human papillomavirus and anogenital caners","volume":"30","author":"Mosciki","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0440","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMcp1210379","article-title":"Cervical-cancer screening with human papillomavirus and cytologie cotesting","volume":"369","author":"Schiffman","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0445","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-3083.2011.02662.x","article-title":"IL-10 contributes to the suppressive function of tumour-associated myeloid cells and enhances myeloid cell accumulation in tumours","volume":"75","author":"Wang","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0450","first-page":"369","article-title":"IL-10 expression is regulated by HPV E2 protein in cervical cancer cells","volume":"4","author":"Berm\u00fadez-Morales","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0455","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0166-3542(02)00070-0","article-title":"Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5\u2019-segment of the upstream regulatory region (URR)","volume":"55","author":"Arany","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0460","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000445161","article-title":"Cytokines of cervical mucosa and human papilloma virus infection of the cervix: a descriptive study","volume":"60","author":"Daniilidis","year":"2016","journal-title":"Acta Cytol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0465","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.1007\/s13277-015-3868-2","article-title":"Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes","volume":"36","author":"Tan","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0470","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/vim.2006.19.468","article-title":"E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor \u03b2 1 promoter throughout sp1 recognition sequence","volume":"19","author":"Peralta-Zaragoza","year":"2006","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0475","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4049\/jimmunol.167.2.773","article-title":"Regulation of TGF-beta response during T cell activation is modulated by IL-10","volume":"167","author":"Cottrez","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0480","first-page":"533","article-title":"Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix","volume":"49","author":"Mindiola","year":"2008","journal-title":"Invest. Clin."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0485","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/07357900802112693","article-title":"Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape","volume":"26","author":"Bermudez-Morales","year":"2008","journal-title":"Cancer Invest."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0490","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.humimm.2012.06.003","article-title":"Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia","volume":"73","author":"Peghini","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0495","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0153274","article-title":"Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study","volume":"11","author":"Audirac-Chalifour","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0500","first-page":"350","article-title":"Role of IL-10 in immune suppression in cervical cancer","volume":"44","author":"Bhairavabhotla","year":"2007","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0505","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","article-title":"Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection","volume":"89","author":"Clerici","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0510","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/path.929","article-title":"Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer","volume":"195","author":"El-Sherif","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0515","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cytogfr.2007.01.015","article-title":"Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape","volume":"18","author":"Salazar-Onfray","year":"2007","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0520","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1006\/cyto.2001.0909","article-title":"Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia","volume":"14","author":"Tjiong","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0525","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/1547691X.2011.642419","article-title":"Concentration levels of IL-10 and TNF\u03b1 cytokines in patients with human papilloma virus (HPV) DNA+ and DNA\u2212 cervical lesions","volume":"9","author":"Ali","year":"2012","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0530","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3109\/07357909809050029","article-title":"Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer","volume":"16","author":"Chopra","year":"1998","journal-title":"Cancer Invest."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0535","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.1158\/0008-5472.CAN-04-1091","article-title":"Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection","volume":"64","author":"Kobayashi","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0540","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/vim.2006.19.481","article-title":"In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells","volume":"19","author":"Alcocer-Gonz\u00e1lez","year":"2006","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0545","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6058147","article-title":"Tumor-associated macrophages and neutrophils in tumor microenvironment","volume":"2016","author":"Kim","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0550","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.4049\/jimmunol.166.8.5018","article-title":"HLA-G2, \u2212G3, and \u2212G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis","volume":"166","author":"Riteau","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0555","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000334089","article-title":"Altered HLA class I and HLA-G expression is associated with IL-10 expression in patients with cervical cancer","volume":"79","author":"Rodr\u00edguez","year":"2012","journal-title":"Pathobiology"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0560","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2119\/molmed.2015.00083","article-title":"Human leukocyte antigen-G (HLA-G) expression in cancers: roles in immune evasion, metastasis and target for therapy","volume":"21","author":"Lin","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0565","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijgo.2007.03.041","article-title":"Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma","volume":"98","author":"Yoon","year":"2007","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0570","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1177\/1933719110369183","article-title":"Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16\/18 infection, and host immune response","volume":"17","author":"Dong","year":"2010","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0575","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/jnci\/dji269","article-title":"Researchers attempting to define role of cytokines in cancer risk","volume":"97","author":"Brower","year":"2005","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0580","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/j.1471-0528.2006.00956.x","article-title":"The IL-10 \u22121082G polymorphism is associated with clearance of HPV infection","volume":"113","author":"Farzaneh","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0585","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1128\/JVI.74.10.4729-4737.2000","article-title":"Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes","volume":"74","author":"Santin","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2017.03.002_bib0590","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00428-009-0850-7","article-title":"Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort","volume":"455","author":"Syrj\u00e4nen","year":"2009","journal-title":"Virchows Arch."}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610117300060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610117300060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T15:55:16Z","timestamp":1692719716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610117300060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":118,"alternative-id":["S1359610117300060"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2017.03.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}